Buscar
01/04/2026
Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)
González, JG, Magaña, JG, Llàcer, P, Pal, AF, Trullàs, JC, Zegrí-Reiriz, I, Díez-Villanueva, P, Fernandez, AE, Manzano, LP, Fernández, ABM, Pérez, PC, López-Azor, JC, Martínez, R, D'Amato, M, Pascual, CF, Ruiz-Ruiz, E, Pisón, EP, Anter, MB, Marcos, MC. Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI). ESC Heart Failure. 2026; 13(2)DOI:10.1093/eschf/xvag096. PMID:41920937. IF:3.700(Q1/3D).
01/06/2026
Thrombospondin-4 is upregulated in abdominal aortic aneurysm: A vasoprotective response with potential therapeutic relevance
Blanco-Casoliva, L, Puertas-Umbert, L, Alonso, J, Almendra-Pegueros, R, Varona, S, Camacho, M, Arderiu, G, Asmarats, L, Alegret, M, Martinez-Gonzalez, J, Rodriguez, C. Thrombospondin-4 is upregulated in abdominal aortic aneurysm: A vasoprotective response with potential therapeutic relevance. BRITISH JOURNAL OF PHARMACOLOGY. 2026; 183(12)DOI:10.1111/bph.70402. PMID:41814667. IF:7.700(Q1/1D).
01/04/2026
Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Synowiec, E, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Heart Transplant Recipients
Bermejo, ZB, Severo, A, Groba, M, Martínez-Solé, J, Molina, BD, Simón, C, Villalba, GC, Cosio, MG, García-Quintana, A, López-Vilella, R, Fernández, VA, De Antonio, M, Ortiz-Bautista, C. Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Heart Transplant Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
07/05/2026
Novel treatment strategies in cardiogenic shock: an update on ongoing clinical trials
Padilla-Lopez, M, Manicone, F, Holle, SLD, Wenzl, FA, Kimmoun, A, Mebazaa, A, Sionis, A. Novel treatment strategies in cardiogenic shock: an update on ongoing clinical trials. HEART FAILURE REVIEWS. 2026; 31(1)DOI:10.1007/s10741-026-10637-z. PMID:42095992. IF:4.200(Q1/3D).
21/04/2026
Biomarkers for Cardiovascular Drug Development
Aimo, A, Butler, J, De Michieli, L, Mendieta, G, Zannad, F, Januzzi, JL. Biomarkers for Cardiovascular Drug Development. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2026; 87(15)DOI:10.1016/j.jacc.2025.12.072. PMID:41670555. IF:22.300(Q1/1D).
01/01/2026
Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU
Vivas, D, Ferrandis, R, Anguita-Sánchez, M, Anguita-Gámez, M, Arcelus, JI, Echeverri, M, Egocheaga, I, Esteve-Pastor, MA, Ferreiro, JL, Llau, JV, Roldán, V, Ruiz-Nodar, JM, González-Casal, D, Torres-Fonseca, M, López-Menéndez, J, Ciria, M, Leyva, F, de Santiago, ER, Vidán, MT, Pamplona, L, Mingot-Castellano, ME, Mateo-Arranz, J, Polo, J, Castellanos, A, Llanos, C, Madridano, O, Jiménez, S, Freijo, MD, Puchades, MJ, Lafuente, J, Jiménez, D, Santos-Bueso, E, Ferrandis, E, Figuero, E, González-Nieto, CJ, Castel, A, Hermida, JF, Marín, F, Rodríguez-Padial, L, Fernández-Lozano, I, Hidalgo, F, Cassinello, C, Muñoz, E, Palomo-López, N. Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(1)DOI:10.1016/j.rec.2025.09.003. PMID:40983168. IF:4.900(Q1/2D).
01/01/2026
Evaluation of Fibrinolysis Testing Methods in Haemostasis and Thrombosis Laboratories: Results of a National Survey by the Spanish Society on Thrombosis and Haemostasis (SETH) Laboratory Working Group
Revilla, N, Gutierrez, AB, Alén, AR, Martínez, AM, Franco, CA, Díaz, CG, Alonso, CM, Aisa, CS, Jiménez, DF, Espino, EM, Arteta, EG, Jaime, FJL, Ortega, IS, Martíinez, IM, Upegui, I, Pego, JM, Tovar, JC, Vila, JGA, Bastida, JM, Juaristi, KA, Lopez, MR, Rodríguez, MF, Paloma, MJ, Muñoz, MJS, Jubilar, MM, Massaro, MT, Docampo, MF, Miguélez, MSO, Vilalta, N, Sebastian, OG, Culebras, RA, Giner, VC, Villas, JMC, Butta, N. Evaluation of Fibrinolysis Testing Methods in Haemostasis and Thrombosis Laboratories: Results of a National Survey by the Spanish Society on Thrombosis and Haemostasis (SETH) Laboratory Working Group. HAEMOPHILIA. 2026; 32DOI:. PMID:. IF:3.000(Q2/4D).